儿童抗NMDA受体脑炎临床分析并文献复习

doi:10.3969/j.issn.1000-8535.2017.06.011

摘要/Abstract

摘要： 目的探究儿童抗NMDA受体脑炎临床特点、诊治及预后。方法回顾性分析16例儿童抗NMDA受体脑炎的临床表现、辅助检查、治疗与预后。结果 16例患儿中,意识障碍16例, 语言障碍15例,运动障碍13例,11例惊厥发作。9例脑脊液NMDA受体抗体阳性,14例血清NMDA受体抗体阳性。16例患儿脑电图均出现背景中高波幅慢活动,头颅磁共振检查未见异常。所有患儿均接受丙种球蛋白联合激素冲击治疗,14例症状缓解,2例需加用利妥昔单抗治疗,症状缓解。结论识别儿童抗NMDA受体脑炎多样临床表现,筛查NMDA受体抗体有助于早期诊断及治疗儿童抗NMDA受体脑炎。

关键词: NMDA, 儿童, 脑炎

Abstract: Objective To investigate clinical features, diagnosis, treatment and prognosis of the patient with anti-NMDA receptor encephalitis in children. Methods The data of clinical feature,auxiliary examination of 16 cases with anti-NMDA receptor encephalitis in children were reviewed and analyzed. Results Of all 16 cases, there were 16 cases with decreased consciousness, 15 cases developed speech alteration, 13 cases developed movements disorder and 11 cases with seizure. Cerebrospinal fluid NMDA antibody were positive in 9 cases and serum NMDA antibody were positive in 14 cases. The EEG of 16 patients showed high-amplitude slow activity in the background. There were no significant abnormalities in head magnetic resonance imaging (MRI) of all children. After all children received gamma globulin combined hormone therapy, 14 cases had boen improved and another 2 cases need to be further treated combined with Rituximab. Conclusion Pediatric patients had diverse clinical manifestations. Screening of NMDA receptor antibody may help early diagnosis of anti-NMDA receptor encephalitis. And timely treatment may yield a favorable prognosis.

Key words: NMDA, Children, Encephalitis

朱海霞, 李小晶, 王秀英, 梁惠慈. 儿童抗NMDA受体脑炎临床分析并文献复习[J]. 广州医药, 2017, 48(6): 36-39.

ZHU Haixia, LI Xiaojing, WANG Xiuying, LIANG Huici. Clinical analysis of anti-NMDA receptor encephalitis in children and literature review[J]. Guangzhou Medical Journal, 2017, 48(6): 36-39.

参考文献

[1] BATALLER L, KLEOPA K A, WU G F, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes[J]. J Neurol Neurosurg Psychiatry, 2007,78(4): 381-385.
[2] Pérez E, RUGGIERI V, MONGES S, et al. Acute encephalitis anti-ionotropic glutamate receptor activated N-methyl-D-aspartate (NMDAR): analysis of eleven pediatric cases in Argentina(Benito Yelin Award)[J]. Medicina (B Aires), 2013, 73(Suppl 1): 1-9.
[3] GABLE M S, SHERIFF H, DALMAU J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project[J]. Clin Infect Dis, 2012,54(7): 899-904.
[4] LOUGHAN A R, ALLEN A, PERNA R, et al. Anti-n-methyl-d-aspartate receptor encephalitis: a review and neuropsychological case study[J]. Clin Neuropsychol, 2016,30(1):150-163.
[5] BRENTON J N, KIM J, SCHWARTZ R H. Approach to the management of pediatric-onset anti-n-methyl-d-aspartate (anti-nmda) receptor encephalitis: a case series[J]. J Child Neurol, 2016,31(9):1150-1155.
[6] ANDREA P MANN, ELENA GREBENCIUCOVA, RIMAS V LUKAS. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges[J]. Ther Clin Risk Manag, 2014, 10: 517-525.
[7] THAÍS ARMANGUE, MAR PETIT-PEDROL, JOSEP DALMAU. Autoimmune encephalitis in children[J]. J Child Neurol, 2012, 27(11): 1460-1469.
[8] NAZIF T M, Vázquez J, HONIG L S, et al. Anti-N-methyl-d-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction[J]. Dizon Europace, 2012, 14(8): 1188-1194.
[9] FRANCESC GRAUS, MAARTEN J TITULAER, RAMANI BALU,et al. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4): 391-404.
[10] DALMAU J,ROSENFELD M R. Autoimmune encephalitis update[J]. Neuro Oncol, 2014, 16 (6): 771-778.
[11] TITULAER M J, MCCRACKEN L, GABILONDO I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013,12(2):157-165.
[12] BARTOLINI L, MUSCAL E. Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey[J]. J Neurol, 2017, 264(4):647-653.
[13] DALE R C, BRILOT F, DUFFY L V,et al.Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease[J]. Neurology, 2014, 8;83(2):142-150.
[14] TITULAER M J, MCCRACKEN L, GABILONDO I, et al.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013, 12(2): 157-165.
[15] BYRNE S, WALSH C, HACOHEN Y, et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome[J]. Neurol Neuroimmunol Neuroinflamm, 2015, 2(4): e130.